Amid a major boom in usage of GLP-1 weight management medication in the US, the National Confectioners Association has revealed that patients are still able to enjoy candy options in their diets, writes Neill Barston. This is especially the case given a sustained growth in health and well-being, and better-for-you product ranges, which candy manufacturers are increasingly responding to. Moreover, as asserted by the NCA, GLP-1 consumers remain highly engaged with confectionery, with consumption patterns similar to non-users. The report also finds that broader economic pressures are having a greater impact on confectionery consumption than GLP-1 medications. “Consumers taking GLP-1 medications continue to enjoy chocolate and candy – they’re simply approaching treats more intentionally.